AU2002361390A1 - Anti-cd7 immunotoxin as fusion protein - Google Patents

Anti-cd7 immunotoxin as fusion protein

Info

Publication number
AU2002361390A1
AU2002361390A1 AU2002361390A AU2002361390A AU2002361390A1 AU 2002361390 A1 AU2002361390 A1 AU 2002361390A1 AU 2002361390 A AU2002361390 A AU 2002361390A AU 2002361390 A AU2002361390 A AU 2002361390A AU 2002361390 A1 AU2002361390 A1 AU 2002361390A1
Authority
AU
Australia
Prior art keywords
immunotoxin
fusion protein
fusion
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002361390A
Other versions
AU2002361390A8 (en
Inventor
Georg Heinrich Maximilian Fey
Martin Gramatzki
Matthias Peipp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Friedrich Alexander Univeritaet Erlangen Nuernberg FAU
Original Assignee
Friedrich Alexander Univeritaet Erlangen Nuernberg FAU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friedrich Alexander Univeritaet Erlangen Nuernberg FAU filed Critical Friedrich Alexander Univeritaet Erlangen Nuernberg FAU
Publication of AU2002361390A1 publication Critical patent/AU2002361390A1/en
Publication of AU2002361390A8 publication Critical patent/AU2002361390A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2002361390A 2001-12-14 2002-12-11 Anti-cd7 immunotoxin as fusion protein Abandoned AU2002361390A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33942201P 2001-12-14 2001-12-14
US60/339,422 2001-12-14
PCT/EP2002/014064 WO2003051926A2 (en) 2001-12-14 2002-12-11 Anti-cd7 immunotoxin as fusion protein

Publications (2)

Publication Number Publication Date
AU2002361390A1 true AU2002361390A1 (en) 2003-06-30
AU2002361390A8 AU2002361390A8 (en) 2003-06-30

Family

ID=23328933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002361390A Abandoned AU2002361390A1 (en) 2001-12-14 2002-12-11 Anti-cd7 immunotoxin as fusion protein

Country Status (2)

Country Link
AU (1) AU2002361390A1 (en)
WO (1) WO2003051926A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1748050A1 (en) * 2005-07-28 2007-01-31 Rijksuniversiteit Groningen Targeting-enhanced activation of galectins
US20070178103A1 (en) * 2006-01-30 2007-08-02 Fey Georg H CD19-specific immunotoxin and treatment method
US20100015661A1 (en) * 2006-04-21 2010-01-21 Mab-Factory Gmbh Antibody-rnase-conjugate
AU2008321026B2 (en) * 2007-11-13 2014-01-16 The Scripps Research Institute Production of cytotoxic antibody-toxin fusion in eukaryotic algae
BR112013002334A2 (en) 2010-07-30 2016-05-24 Medimmune Llc method for purifying active polypeptides or immunoconjugates.
CN102154355A (en) * 2011-01-06 2011-08-17 武汉大学 Recombinant immunotoxin CCL25-PE38 gene and preparation method as well as application thereof
CN102161998B (en) * 2011-01-14 2013-01-09 中国人民解放军军事医学科学院附属医院 Deoxyribonucleic acid (DNA) vaccine based on B7-1-PE40KDEL exotoxin fusion gene and application thereof
KR101521224B1 (en) 2012-12-20 2015-05-19 한양대학교 산학협력단 Humanized single chain fragment antibody(scFv) carrier specific for T cell
SG11201706236SA (en) 2015-02-06 2017-08-30 Nat Univ Singapore Methods for enhancing efficacy of therapeutic immune cells
US11390658B2 (en) 2016-06-06 2022-07-19 St. Jude Children's Research Hospital Anti-CD7 chimeric antigen receptor and method of use thereof
CA3032429A1 (en) * 2016-08-03 2018-02-08 Washington University Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
CN110268049A (en) * 2016-11-22 2019-09-20 新加坡国立大学 CD7 for T cell malignant tumour immunotherapy expresses retarding agent and Chimeric antigen receptor
US11648269B2 (en) 2017-08-10 2023-05-16 National University Of Singapore T cell receptor-deficient chimeric antigen receptor T-cells and methods of use thereof
CA3101505A1 (en) * 2018-05-31 2019-12-05 Washington University Chimeric antigen receptor t cells (car-t) for the treatment of cancer
WO2023155852A1 (en) * 2022-02-17 2023-08-24 上海优替济生生物医药有限公司 Modified immune effector cells and uses thereof
CN114560943B (en) * 2022-02-28 2022-12-16 先进生物(苏州)有限公司 CD7-CAR-T cell and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372217B1 (en) * 1997-06-03 2002-04-16 Regents Of The University Of Minnesota Methods for the treatment of CD7+ viral infection with TXU-7-PAP
ATE452196T1 (en) * 2000-05-18 2010-01-15 Us Gov Health & Human Serv IMMUNTOXIN FUSION PROTEINS AND AGENT FOR EXPRESSING THEM

Also Published As

Publication number Publication date
AU2002361390A8 (en) 2003-06-30
WO2003051926A3 (en) 2003-09-04
WO2003051926A2 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
AU2002254724A1 (en) Dual-profile steerable catheter
AU2002364586A1 (en) Albumin fusion proteins
AU2002364587A1 (en) Albumin fusion proteins
AU2001291049A1 (en) Defensin-antigen fusion proteins
AU2002332041A1 (en) Albumin fusion proteins
AU2002361390A1 (en) Anti-cd7 immunotoxin as fusion protein
AU2002224866A1 (en) Homocinetic fixed joint
AU2002357891A1 (en) Dtat fusion toxin
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2001275667A1 (en) Homocinetic joint
AUPR807101A0 (en) Csf-1 immunomodulation
AU2002229675A1 (en) Selective cytotoxic fusion proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2002367161A1 (en) Immunoglobulin composition
AU2001284748A1 (en) Reaper protein
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2001278777A1 (en) Irap-binding protein
AU2001231918A1 (en) Scscntfr/nnt-1 fusion protein
AU2002357873A1 (en) Carbohydrate-associated proteins
AU2002326909A1 (en) Neurotransmission-associated proteins
AU2002306943A1 (en) Reducing the immunogenicity of fusion proteins
AU2002356201A1 (en) Infrared welder
AU2002248517A1 (en) Rax-related protein
AU2002252239A1 (en) Steap-related protein
AU2002243916A1 (en) Timm8b-related protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase